NAICS category

Biological Product (except Diagnostic) Manufacturing

NAICS 325414

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

Part of Manufacturing →

$484.6M
Federal awards
FY2026 · data still posting
10
Recipients
NAICS 325414
Code

NAICS code 325414 (Biological Product (except Diagnostic) Manufacturing) accounted for $484.6M in federal contracts in FY2026, led by the Department of Health and Human Services, across 10 recipients. Its largest recipient on record was Advanced Technology International, with 47%. FY2026 ended Sep 30 and its data is still posting. Computed

Obligations by year

Computed
$3.2B
FY20
$20.4B
FY21
$3.2B
FY22
$657.5M
FY23
$1.7B
FY24
$87.2M
FY25
$484.6M
FY26 partial
▼ 97%
FY20 to FY25

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Biological Product (except Diagnostic) Manufacturing (NAICS 325414) accounted for $484.6M in federal obligations in FY2026, compared with $87.2M in FY2025.
  • The Department of Health and Human Services provided 72% of it.
  • Its largest recipient was Advanced Technology International, with 47%.

Top recipients

Computed
Advanced Technology International$228.3M
Seqirus Inc$54.5M
Sanofi Vaccines US Inc.$23.1M
University of Georgia Research Foundation, Inc.$263.3K

Recipient breakdown available for 63% of obligations shown

Awards

Source

Largest FY2026 awards in this category

Awards coded NAICS 325414 that started in FY2026, by the amount obligated on each so far.

No award on record in this category started in FY2026.

Largest awards in this category

COVID-19 Vaccine Production
awarded 2020$11.1B
Production of Therapeutic in Support of National Emergency Response to…
awarded 2021$5.6B
COVID-19 Vaccines for International Donation
awarded 2021$4.2B
Development of Mrna Vaccine to Licensure for the Prevention of COVID-19. CLIN…
awarded 2020$1.8B
Vaccine for Children 2011
awarded 2011$1.3B
ACAM2000, Smallpox (Vaccinia) Vaccine, Live (Acam)
awarded 2019$857.6M
Vaccine for Children 2011
awarded 2011$640M
Anthrax Vaccine
awarded 2016$601.6M

Total value over each award’s life, largest first.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.